Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
AHA 2025
AG10 - AHA 2025 - VA Prevalence_Geographic Disparities.pdf
AG10 - AHA 2025 - Vutrisiran HCRU and discontinuation.pdf
AG10 - AHA 2025 - ACM CVH (early HF and AF)_v6.0.pdf
AG10 - AHA 2025 - Afib at BL_ePoster_v7.0.pdf
AG10 - AHA 2025 - Afib NT-proBNP_Poster_v8.0.pdf
AG10 - AHA 2025 - ITT analysis.pdf
AG10 - AHA 2025 - CVM CVH by sTTR range_v8.0.pdf
AG10 - AHA 2025 - Demographic Disparities.pdf
AG10-AHA-2025-OLE-M42-ACM-and-ACMCVH-Subgroup.pdf